Conceptual portrait of a woman with eyes closed, surrounded by DNA and RNA imagery.

GOING DEEPER. SEEING MORE.

Don’t accept
partial results.

Comprehensive DNA and RNA profiling for a more complete view of cancer—and clearer direction for what comes next.

SCIENCE WITH A HUMAN PURPOSEExplore the GTC difference ↓
DNA + RNAComplementary molecular insights
Tissue + liquid biopsySolid tumors and hematology
Timely answersSee test-specific turnaround times
Quality at the core ↗View licenses and certifications

THE MOLECULAR PICTURE MATTERS

Cancer is complex.
Your testing should
see more of it.

A mutation is one part of the story. Gene fusions, expression and splicing can add clinically relevant information that DNA testing alone may leave unexplored.

GTC brings these perspectives together to help clinicians interpret the disease and evaluate what comes next.

Why GTC ↗
Conceptual violet tumor cell with jade DNA and orange RNA strands.
DNA+RNATwo perspectives. A more complete picture.

WHY GTC

From molecular detail
to meaningful direction.

Technology matters most when it helps answer the question in front of you.

01

Comprehensive profiling

Bring mutations and RNA findings into the same evaluation, with test options for solid tumors, blood cancers and liquid biopsy.

02

Clinically meaningful interpretation

Put molecular findings in context with expert interpretation and information relevant to treatment and diagnostic discussions.

03

Timely answers

Plan around the clinical question. Review published turnaround times and specimen requirements for the test you need.

04

Flexible access

Send testing to GTC or explore a laboratory partnership that brings genomic capabilities into your organization.

FIND THE RIGHT TEST

Start with the
clinical question.

Explore testing by disease area and sample type. Your care team determines the appropriate test.

Compare scope, specimen requirements and turnaround times on each test page. Ready to order? ↗

CHOOSE YOUR PATH

Different needs.
A clear way forward.

01 / CLINICIANS

Make your next
testing decision.

Find the appropriate test, check specimen requirements and arrange testing.

Explore testing ↗
02 / LABORATORIES & HEALTH SYSTEMS

Build the capability
your team needs.

Outsource testing or explore bringing genomic testing in-house through GTC’s cooperative model.

Explore laboratory partnerships ↗
03 / PHARMA & RESEARCH

Move discovery
toward application.

Explore sequencing, biomarker and customized assay support for research and clinical trials.

Explore research services ↗
Conceptual patient portrait with brain, CSF and molecular imagery.
TISSUE. BLOOD. CSF.One commitment to a more complete picture.

INNOVATION IN PRACTICE / LIQUID TRACE®

A different sample.
The same depth
of purpose.

Liquid Trace brings cell-free DNA and RNA profiling to blood and cerebrospinal fluid, adding molecular information to the broader clinical evaluation.

Explore distinct options for solid tumors, hematologic malignancies and cancers affecting the central nervous system.

Liquid biopsy complements other testing. A negative result does not rule out cancer.

SCIENCE & INNOVATION

Built on evidence.
Advanced through collaboration.

Explore publications ↗
Conceptual relationship between tissue microscopy and molecular information.

FEATURED PUBLICATION / 2023

Recognizing BRCA-like genomic patterns with machine learning.

Explore GTC’s published approach to homologous recombination deficiency assessment using targeted sequencing data.

Read the study ↗

GENOMIC TESTING COOPERATIVE

Advancing molecular testing.
Together.

GTC connects genomic testing, interpretation and laboratory partnership to support the people moving cancer care forward.

Discover the cooperative model ↗

NEWS & RESOURCES

Keep the conversation moving.

LET’S FIND YOUR NEXT STEP

Your testing needs.
Your partnership goals.
Let’s talk.

Talk With GTC ↗